Guardant Health, Inc. Quarterly Operating Income (Loss) in USD from Q3 2017 to Q2 2024

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Guardant Health, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2017 to Q2 2024.
Guardant Health, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$101M, a 15.9% increase year-over-year.
Guardant Health, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$511M, a 6.07% increase year-over-year.
Guardant Health, Inc. annual Operating Income (Loss) for 2023 was -$565M, a 3.74% decline from 2022.
Guardant Health, Inc. annual Operating Income (Loss) for 2022 was -$544M, a 32.5% decline from 2021.
Guardant Health, Inc. annual Operating Income (Loss) for 2021 was -$411M, a 61.2% decline from 2020.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q2 2024	-$511M	-$101M	+$19M	+15.9%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-07
Q1 2024	-$530M	-$99.7M	+$34.4M	+25.6%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-09
Q4 2023	-$565M	-$198M	-$51.4M	-35.2%	Oct 1, 2023	Dec 31, 2023	10-K	2024-02-22
Q3 2023	-$513M	-$114M	+$31.1M	+21.5%	Jul 1, 2023	Sep 30, 2023	10-Q	2023-11-06
Q2 2023	-$544M	-$120M	+$10.7M	+8.21%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-07
Q1 2023	-$555M	-$134M	-$10.7M	-8.69%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-09
Q4 2022	-$544M	-$146M	-$47.9M	-48.8%	Oct 1, 2022	Dec 31, 2022	10-K	2024-02-22
Q3 2022	-$496M	-$145M	-$37.3M	-34.8%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-06
Q2 2022	-$459M	-$130M	-$32.7M	-33.5%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-03
Q1 2022	-$426M	-$123M	-$15.5M	-14.3%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-09
Q4 2021	-$411M	-$98.2M	-$7.04M	-7.72%	Oct 1, 2021	Dec 31, 2021	10-K	2024-02-22
Q3 2021	-$404M	-$107M	-$33M	-44.5%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-03
Q2 2021	-$371M	-$97.6M	-$43M	-78.8%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-04
Q1 2021	-$328M	-$108M	-$73M	-209%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-05
Q4 2020	-$255M	-$91.2M	-$65.2M	-251%	Oct 1, 2020	Dec 31, 2020	10-K	2023-02-23
Q3 2020	-$190M	-$74.3M	-$56.8M	-325%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-04
Q2 2020	-$133M	-$54.6M	-$39.4M	-258%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-05
Q1 2020	-$93.6M	-$34.9M	-$11.2M	-47.5%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-06
Q4 2019	-$82.4M	-$26M	+$1.43M	+5.2%	Oct 1, 2019	Dec 31, 2019	10-K	2022-02-24
Q3 2019	-$83.8M	-$17.5M	+$6.73M	+27.8%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-05
Q2 2019	-$90.5M	-$15.3M	+$7.44M	+32.7%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-06
Q1 2019	-$98M	-$23.7M	-$5.02M	-26.9%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-07
Q4 2018	-$92.9M	-$27.4M			Oct 1, 2018	Dec 31, 2018	10-K	2021-02-25
Q3 2018		-$24.2M	+$4.47M	+15.6%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-07
Q2 2018		-$22.7M			Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-07
Q1 2018		-$18.6M			Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-10
Q3 2017		-$28.7M			Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-19

* An asterisk sign (*) next to the value indicates that the value is likely invalid.